Arvinas (ARVN) News Today → My top 100 stocks… (From DTI) (Ad) Free ARVN Stock Alerts $32.37 +0.77 (+2.44%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArvinas appoints new chief business officerinvesting.com - April 26 at 2:27 PMArvinas Inc.: Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officerfinanznachrichten.de - April 26 at 9:27 AMFederated Hermes Inc. Has $5.68 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - April 26 at 5:40 AMArvinas Appoints Randy Teel, Ph.D., as Chief Business Officerglobenewswire.com - April 24 at 4:30 PMArvinas, Inc. (NASDAQ:ARVN) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 21 at 2:44 AMArvinas, Inc. (ARVN)finance.yahoo.com - April 20 at 7:36 PMInternational Assets Investment Management LLC Buys Shares of 53,508 Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - April 20 at 4:42 AMVontobel Holding Ltd. Takes $2.72 Million Position in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - April 19 at 5:37 AMArvinas, Inc. (NASDAQ:ARVN) Short Interest Updatemarketbeat.com - April 16 at 12:42 AMHC Wainwright Lowers Arvinas (NASDAQ:ARVN) Price Target to $87.00marketbeat.com - April 12 at 8:14 AMBuy Rating Affirmed for Arvinas Amid Strategic Novartis Deal and Growth Potentialmarkets.businessinsider.com - April 11 at 7:39 PMBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Optionsinvestors.com - April 11 at 9:17 AMArvinas Enters Deal With Novartis For License Of ARV-766, Sale Of AR-V7 Program; Stock Jumpsmarkets.businessinsider.com - April 11 at 8:08 AMArvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancerglobenewswire.com - April 11 at 7:00 AMSG Americas Securities LLC Lowers Stake in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - April 11 at 4:11 AMVanguard Group Inc. Buys 90,426 Shares of Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - April 6 at 4:14 AMWellington Management Group LLP Decreases Stock Position in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - March 29 at 4:09 AMArvinas (NASDAQ:ARVN) Stock Rating Reaffirmed by Truist Financialmarketbeat.com - March 25 at 1:11 PMAmerican Century Companies Inc. Reduces Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - March 22 at 4:17 AMArvinas gets new chief medical officerseekingalpha.com - March 20 at 11:20 PMArvinas (NASDAQ:ARVN) Shares Gap Down to $42.60marketbeat.com - March 19 at 11:53 AMArvinas gets new chief medical headmsn.com - March 19 at 11:30 AMArvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officerglobenewswire.com - March 18 at 4:40 PMShort Interest in Arvinas, Inc. (NASDAQ:ARVN) Increases By 7.5%marketbeat.com - March 18 at 11:24 AMArvinas to Participate in Upcoming Investor Conferencesglobenewswire.com - March 4 at 7:00 AMArvinas, Inc. (NASDAQ:ARVN) Short Interest Up 19.5% in Februarymarketbeat.com - March 3 at 10:25 AMArvinas: Behind The Huge Rallyseekingalpha.com - March 3 at 6:25 AMArvinas (NASDAQ:ARVN) Stock Price Up 5.6% on Analyst Upgrademarketbeat.com - March 3 at 1:04 AMFederated Hermes Inc. Makes New $2.05 Million Investment in Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - March 2 at 5:54 AMArvinas, Inc. (NASDAQ:ARVN) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - March 2 at 1:59 AMArvinas, Inc. (NASDAQ:ARVN) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?finance.yahoo.com - March 1 at 10:52 AMArvinas (NASDAQ:ARVN) Shares Up 5.6% After Analyst Upgrademarketbeat.com - March 1 at 10:15 AMHC Wainwright Weighs in on Arvinas, Inc.'s FY2024 Earnings (NASDAQ:ARVN)marketbeat.com - March 1 at 8:29 AMCorton Capital Inc. Purchases 12,411 Shares of Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - February 29 at 11:22 AMArvinas, Inc. Expected to Earn FY2028 Earnings of $3.68 Per Share (NASDAQ:ARVN)marketbeat.com - February 29 at 9:45 AMArvinas (NASDAQ:ARVN) Given New $60.00 Price Target at Barclaysmarketbeat.com - February 29 at 9:29 AMArvinas Holding Company: Buy Rating Backed by Promising Breast Cancer Therapy and Strategic Expansion into Parkinson’s Disease Treatmentmarkets.businessinsider.com - February 28 at 3:53 PMPiper Sandler Keeps Their Buy Rating on Arvinas Holding Company (ARVN)markets.businessinsider.com - February 28 at 3:53 PMHC Wainwright Reaffirms "Buy" Rating for Arvinas (NASDAQ:ARVN)marketbeat.com - February 28 at 1:46 PMNavigating 7 Analyst Ratings For Arvinasmarkets.businessinsider.com - February 28 at 10:53 AMBuy Rating Affirmed for Arvinas Holding Company Amid Strong Drug Candidate Prospects and Robust Financial Healthmarkets.businessinsider.com - February 28 at 10:53 AMArvinas (NASDAQ:ARVN) Announces Quarterly Earnings Resultsmarketbeat.com - February 28 at 10:27 AMBMO Capital Markets Boosts Arvinas (NASDAQ:ARVN) Price Target to $90.00marketbeat.com - February 28 at 9:38 AMAvidity Partners Management LP Sells 158,229 Shares of Arvinas, Inc. (NASDAQ:ARVN)marketbeat.com - February 27 at 4:24 PMArvinas: Q4 Earnings Insightsbenzinga.com - February 27 at 1:27 PMArvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - February 27 at 7:00 AMArvinas (NASDAQ:ARVN) shareholders are still up 143% over 5 years despite pulling back 10% in the past weekfinance.yahoo.com - February 24 at 10:30 AMArvinas CFO Cassidy to Depart, Teel to Take Over on Interim Basismarketwatch.com - February 22 at 7:03 AMWhat Makes Arvinas, Inc. (ARVN) a Strong Momentum Stock: Buy Now?finance.yahoo.com - February 21 at 4:01 PMArvinas Inc.: Arvinas Announces Chief Financial Officer Transitionfinanznachrichten.de - February 21 at 11:00 AM Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address My top 100 stocks… (Ad)We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well. Get some cool freebies right here. ARVN Media Mentions By Week ARVN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.620.34▲Average Medical News Sentiment ARVN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼43▲ARVN Articles Average Week Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CORT News Today MRUS News Today RYTM News Today TGTX News Today DYN News Today VERA News Today RCKT News Today INDV News Today JANX News Today SMMT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
